Emanuel Krebs

1.1k total citations
49 papers, 631 citations indexed

About

Emanuel Krebs is a scholar working on Epidemiology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Emanuel Krebs has authored 49 papers receiving a total of 631 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Epidemiology, 19 papers in Infectious Diseases and 19 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Emanuel Krebs's work include HIV, Drug Use, Sexual Risk (26 papers), HIV/AIDS Research and Interventions (19 papers) and Opioid Use Disorder Treatment (18 papers). Emanuel Krebs is often cited by papers focused on HIV, Drug Use, Sexual Risk (26 papers), HIV/AIDS Research and Interventions (19 papers) and Opioid Use Disorder Treatment (18 papers). Emanuel Krebs collaborates with scholars based in Canada, United States and Australia. Emanuel Krebs's co-authors include Bohdan Nosyk, Jeong Eun Min, Yih‐Ing Hser, Elizabeth Evans, David Huang, Benjamin Enns, Evan Wood, Linwei Wang, Xiao Zang and Julio Montaner and has published in prestigious journals such as Annals of Internal Medicine, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Emanuel Krebs

46 papers receiving 621 citations

Peers

Countries citing papers authored by Emanuel Krebs

Since Specialization

Citations

This map shows the geographic impact of Emanuel Krebs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emanuel Krebs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emanuel Krebs more than expected).

Fields of papers citing papers by Emanuel Krebs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emanuel Krebs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emanuel Krebs. The network helps show where Emanuel Krebs may publish in the future.

Co-authorship network of co-authors of Emanuel Krebs

This figure shows the co-authorship network connecting the top 25 collaborators of Emanuel Krebs. A scholar is included among the top collaborators of Emanuel Krebs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emanuel Krebs. Emanuel Krebs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical Effectiveness and Cost-Effectiveness of Multigene Panel Sequencing in Advanced Melanoma: A Population-Level Real-World Target Trial Emulation 2025 ·JCO Precision Oncology ·Emanuel Krebs, Deirdre Weymann, Cheryl Ho, Alison M. Weppler, Ian Bosdet, Aly Karsan, Timothy P. Hanna, Samantha Pollard, Dean A. Regier	1
2	Putting the substance in substantial evidence: an evidence-based approach to flexible drug regulation 2025 ·Frontiers in Medicine ·Emanuel Krebs, Tania Bubela, (unknown), Christopher McCabe, Dean A. Regier	1
3	Challenges and Mitigation Strategies in the Development and Feasibility Assessment of a Digital Mental Health Intervention for Depression (VMood): Mixed Methods Feasibility Study 2025 ·JMIR Formative Research ·(unknown), Jill Murphy, Vu Cong Nguyen, (unknown), Harry Minas, Raymond W. Lam, Kanna Hayashi, (unknown), Emanuel Krebs, John O’Neil	1
4	How life-cycle real-world evidence can bridge evidentiary gaps in precision oncology 2025 ·Frontiers in Medicine ·Emanuel Krebs, Deirdre Weymann, Tania Bubela, Dean A. Regier	0
5	“I Just Assumed This Was Already Being Done”: Canadian Patient Preferences for Enhanced Data Sharing for Precision Oncology 2024 ·JCO Precision Oncology ·Samantha Pollard, (unknown), (unknown), Deirdre Weymann, Emanuel Krebs, Cheryl Ho, Howard J. Lim, Steven J.M. Jones, Yvonne Bombard, Timothy P. Hanna, (unknown), Holly Longstaff, Robert Cook‐Deegan, Tania Bubela, Dean A. Regier	1
6	Sensitivity to change of generic preference-based instruments (EQ-5D-3L, EQ-5D-5L, and HUI3) in the context of treatment for people with prescription-type opioid use disorder in Canada 2023 ·Quality of Life Research ·David G. T. Whitehurst, (unknown), Emanuel Krebs, Benjamin Enns, M. Eugenia Socías, Didier Jutras‐Aswad, Bernard Le Foll, Bohdan Nosyk	2
7	Evaluating the effectiveness and cost-effectiveness of a digital, app-based intervention for depression (VMood) in community-based settings in Vietnam: Protocol for a stepped-wedge randomized controlled trial 2023 ·PLoS ONE ·(unknown), Jill Murphy, Vu Cong Nguyen, Hui Xie, Raymond W. Lam, Harry Minas, Yufei Zheng, Emanuel Krebs, Kanna Hayashi, Dao S, Xuân Hưng Nguyễn, (unknown), Eugene Fiume, John O’Neil	3
8	Toward Best Practices for Economic Evaluations of Tumor-Agnostic Therapies: A Review of Current Barriers and Solutions 2023 ·Value in Health ·Deirdre Weymann, Samantha Pollard, (unknown), Emanuel Krebs, Dean A. Regier	9
9	Cost-effectiveness of flexible take-home buprenorphine-naloxone versus methadone for treatment of prescription-type opioid use disorder 2023 ·Drug and Alcohol Dependence ·Benjamin Enns, Emanuel Krebs, David G. T. Whitehurst, Didier Jutras‐Aswad, Bernard Le Foll, M. Eugenia Socías, Bohdan Nosyk	6
10	Opioid analgesic prescribing for opioid‐naïve individuals prior to identification of opioid use disorder in British Columbia, Canada 2021 ·Addiction ·Benjamin Enns, Emanuel Krebs, (unknown), (unknown), Jeong Eun Min, Bohdan Nosyk	2
11	Characterizing opioid agonist treatment discontinuation trends in British Columbia, Canada, 2012–2018 2021 ·Drug and Alcohol Dependence ·Emanuel Krebs, Fahmida Homayra, Jeong Eun Min, (unknown), (unknown), (unknown), Bohdan Nosyk	13
12	The effect of a methadone reformulation on opioid agonist treatment outcomes: A population-based study in British Columbia, Canada, 2013–14 2021 ·Journal of Substance Abuse Treatment ·Emanuel Krebs, (unknown), (unknown), Jeong Eun Min, Kevin Schnepel, Hitoshi Shigeoka, Bohdan Nosyk	1
13	Determinants of selection into buprenorphine/naloxone among people initiating opioid agonist treatment in British Columbia 2019 ·Drug and Alcohol Dependence ·Fahmida Homayra, (unknown), Micah Piske, Lindsay A Pearce, Haoxuan Zhou, Jeong Eun Min, Emanuel Krebs, Bohdan Nosyk	11
14	Structural Design and Data Requirements for Simulation Modelling in HIV/AIDS: A Narrative Review 2019 ·PharmacoEconomics ·(unknown), Xiao Zang, Emanuel Krebs, Linwei Wang, Brandon D. L. Marshall, Reuben Granich, Bruce R. Schackman, Julio Montaner, Bohdan Nosyk	6
15	Developing a dynamic HIV transmission model for 6 U.S. cities: An evidence synthesis 2019 ·PLoS ONE ·Emanuel Krebs, Benjamin Enns, Linwei Wang, Xiao Zang, Dimitra Panagiotoglou, Carlos del Rı́o, Julia C. Dombrowski, Daniel J. Feaster, Matthew R. Golden, Reuben Granich, Brandon D. L. Marshall, Shruti H. Mehta, Lisa R. Metsch, Bruce R. Schackman, Steffanie A. Strathdee, Bohdan Nosyk, (unknown)	23
16	The effect of public health-oriented drug law reform on HIV incidence in people who inject drugs in Tijuana, Mexico: an epidemic modelling study 2018 ·The Lancet Public Health ·Annick Bórquez, Leo Beletsky, Bohdan Nosyk, Steffanie A. Strathdee, (unknown), Daniela Abramovitz, Claudia Rafful, (unknown), Javier Cepeda, Dimitra Panagiotoglou, Emanuel Krebs, Peter Vickerman, Marie‐Claude Boily, Nicholas M. Thomson, Natasha K. Martin	30
17	Initiating HCV treatment with direct acting agents in opioid agonist treatment: When to start for people co-infected with HIV? 2017 ·International Journal of Drug Policy ·Dimitra Panagiotoglou, Emanuel Krebs, Jeong Eun Min, Michelle Olding, Keith Ahamad, Lianping Ti, Julio Montaner, Bohdan Nosyk	5
18	The costs of crime associated with stimulant use in a Canadian setting 2017 ·Drug and Alcohol Dependence ·Benjamin Enns, Emanuel Krebs, Kora DeBeck, Kanna Hayashi, M‐J Milloy, Lindsey Richardson, Evan Wood, Bohdan Nosyk	10
19	The ‘Expanded HIV care in opioid substitution treatment’ (EHOST) cluster-randomized, stepped-wedge trial: A study protocol 2015 ·Contemporary Clinical Trials ·Bohdan Nosyk, Emanuel Krebs, Jeong Eun Min, Keith Ahamad, Jane A. Buxton, Charlie H. Goldsmith, Mark Hull, (unknown), Mel Krajden, (unknown), Michelle Olding, Evan Wood, Julio Montaner	5
20	Cost-effectiveness Analysis Along the Continuum of HIV Care: How Can We Optimize the Effect of HIV Treatment as Prevention Programs? 2014 ·Current HIV/AIDS Reports ·Bohdan Nosyk, Emanuel Krebs, Oghenowede Eyawo, Jeong Eun Min, Rolando Barrios, Julio Montaner	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact